相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
Pascal Benkert et al.
LANCET NEUROLOGY (2022)
Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review
Michelle H. Chen et al.
CNS DRUGS (2020)
Disease-modifying therapy aids cognition in multiple sclerosis
Maria Pia Amato et al.
NATURE REVIEWS NEUROLOGY (2020)
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
Ralph H. B. Benedict et al.
LANCET NEUROLOGY (2020)
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Symbol Digit Modalities Test: A valid clinical trial endpoint for measuring cognition in multiple sclerosis
Lauren Strober et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Cognitive function predicts work disability among multiple sclerosis patients
Andrius Kavaliunas et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2019)
Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial
I. Rorsman et al.
ACTA NEUROLOGICA SCANDINAVICA (2018)
Information processing speed in multiple sclerosis: Past, present, and future
Silvana L. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Information processing speed in multiple sclerosis: Past, present, and future
Silvana L. Costa et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Cognition in multiple sclerosis
Iris-Katharina Penner
NEURODEGENERATIVE DISEASE MANAGEMENT (2017)
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
Pietro Iaffaldano et al.
JOURNAL OF NEUROLOGY (2016)
The Swedish MS registry - clinical support tool and scientific resource
J. Hillert et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis
Annett Kunkel et al.
FRONTIERS IN NEUROLOGY (2015)
Factors That Moderate Activity Limitation and Participation Restriction in People With Multiple Sclerosis
Yael Goverover et al.
AMERICAN JOURNAL OF OCCUPATIONAL THERAPY (2015)
Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing
Lauren Strober et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
C. Lang et al.
EUROPEAN NEUROLOGY (2012)
Impact of Natalizumab on Cognitive Performances and Fatigue in Relapsing Multiple Sclerosis: A Prospective, Open-Label, Two Years Observational Study
Pietro Iaffaldano et al.
PLOS ONE (2012)
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis
Carolina Holmen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
Fredrik Piehl et al.
NEUROLOGICAL SCIENCES (2011)
The effect of natalizumab on cognitive function in patients with relapsing-remitting multiple sclerosis: preliminary results of a 1-year follow-up study
Flavia Mattioli et al.
NEUROLOGICAL SCIENCES (2011)
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
S. A. Morrow et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study
Maria P. Amato et al.
MULTIPLE SCLEROSIS (2010)
Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri (R)) in inflammatory diseases
Olaf Stueve et al.
CNS DRUG REVIEWS (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
